Chapter 9 The Chemokine-Binding Protein M3 as a Tool to Understand the Chemokine Network In Vivo

Methods in Enzymology

Volumn 460, Issue A, 2009, Pages 193-207

  Lira, Sergio A ^a   Viejo Borbolla, Abel ^a,b   Shang, Limin ^a   Martin, Andrea P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CHEMOKINE; CXCL13 CHEMOKINE; INSULIN; M3 PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG; M3 PROTEIN, MURINE GAMMAHERPESVIRUS; VIRUS PROTEIN;

CELL INFILTRATION; CELL MIGRATION; DIABETES MELLITUS; HUMAN; IMMUNOMODULATION; IN VIVO STUDY; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSGENIC MOUSE; TRANSGENICS; ANIMAL; ARTICLE; CELL MOTION; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; RHADINOVIRUS; SIGNAL TRANSDUCTION;

MURID HERPESVIRUS 4;

ANIMALS; CELL MOVEMENT; CHEMOKINES; ISLETS OF LANGERHANS; MICE; MICE, TRANSGENIC; RHADINOVIRUS; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 65549125455     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)05209-4     Document Type: Review

References (38)

1. Adorini L., Gregori S., and Harrison L.C. Understanding autoimmune diabetes: Insights from mouse models. Trends Mol. Med. 8 (2002) 31-38
2. Alcami A. Structural basis of the herpesvirus M3-chemokine interaction. Trends Microbiol. 11 (2003) 191-192
3. Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3 (2003) 36-50
4. Alexander J.M., Nelson C.A., van Berkel V., Lau E.K., Studts J.M., Brett T.J., Speck S.H., Handel T.M., Virgin H.W., and Fremont D.H. Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111 (2002) 343-356
5. Atkinson M.A., and Wilson S.B. Fatal attraction: Chemokines and type 1 diabetes. J. Clin. Invest. 110 (2002) 1611-1613
6. Bouma G., Coppens J.M., Mourits S., Nikolic T., Sozzani S., Drexhage H.A., and Versnel M.A. Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice. Eur J. Immunol. 35 (2005) 2386-2396
7. Cardozo A.K., Proost P., Gysemans C., Chen M.C., Mathieu C., and Eizirik D.L. IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46 (2003) 255-266
8. Chen S.C., Vassileva G., Kinsley D., Holzmann S., Manfra D., Wiekowski M.T., Romani N., and Lira S.A. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168 (2002) 1001-1008
9. Cinamon G., Shinder V., and Alon R. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat. Immunol. 2 (2001) 515-522
10. Eizirik D.L., Korbutt G.S., and Hellerstrom C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J. Clin. Invest. 90 (1992) 1263-1268
11. Elliott J.I., Dewchand H., and Altmann D.M. Streptozotocin-induced diabetes in mice lacking alphabeta T cells. Clin. Exp. Immunol. 109 (1997) 116-120
12. Flodstrom M., Tyrberg B., Eizirik D.L., and Sandler S. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes 48 (1999) 706-713
13. Foulis A.K., and Oakley C.L. The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus. J. Pathol. 152 (1987) 141-148
14. Fuentes M.E., Durham S.K., Swerdel M.R., Lewin A.C., Barton D.S., Megill J.R., Bravo R., and Lira S.A. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J. Immunol. 155 (1995) 5769-5776
15. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89 (1992) 5547-5551
16. Gotoh M., Maki T., Kiyoizumi T., Satomi S., and Monaco A.P. An improved method for isolation of mouse pancreatic islets. Transplantation 40 (1985) 437-438
17. Grewal I.S., Grewal K.D., Wong F.S., Picarella D.E., Janeway Jr. C.A., and Flavell R.A. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 184 (1996) 1963-1974
18. Hogan B., Constantini F., and Lacy L. Manipulating the mouse embryo (1986), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
19. Jensen K.K., Chen S.C., Hipkin R.W., Wiekowski M.T., Schwarz M.A., Chou C.C., Simas J.P., Alcami A., and Lira S.A. Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J. Virol. 77 (2003) 624-630
20. Kolb-Bachofen V., and Kolb H. A role for macrophages in the pathogenesis of type 1 diabetes. Autoimmunity 3 (1989) 145-154
21. Kwon N.S., Lee S.H., Choi C.S., Kho T., and Lee H.S. Nitric oxide generation from streptozotocin. FASEB J. 8 (1994) 529-533
22. Like A.A., and Rossini A.A. Streptozotocin-induced pancreatic insulitis: New model of diabetes mellitus. Science 193 (1976) 415-417
23. Luther S.A., Bidgol A., Hargreaves D.C., Schmidt A., Xu Y., Paniyadi J., Matloubian M., and Cyster J.G. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169 (2002) 424-433
24. Luther S.A., Lopez T., Bai W., Hanahan D., and Cyster J.G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12 (2000) 471-481
25. Martin A.P., Alexander-Brett J.M., Canasto-Chibuque C., Garin A., Bromberg J.S., Fremont D.H., and Lira S.A. The chemokine binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin. J. Immunol. 178 (2007) 4623-4631
26. Martin A.P., Canasto-Chibuque C., Shang L., Rollins B.J., and Lira S.A. The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo. J. Immunol. 177 (2006) 7296-7302
27. Martin A.P., Coronel E.C., Sano G., Chen S.C., Vassileva G., Canasto-Chibuque C., Sedgwick J.D., Frenette P.S., Lipp M., Furtado G.C., and Lira S.A. A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21. J. Immunol. 173 (2004) 4791-4798
28. Martin A.P., Grisotto M.G., Canasto-Chibuque C., Kunkel S.L., Bromberg J.S., Furtado G.C., and Lira S.A. Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice. Diabetes 57 (2008) 387-394
29. Morimoto J., Yoneyama H., Shimada A., Shigihara T., Yamada S., Oikawa Y., Matsushima K., Saruta T., and Narumi S. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis. J. Immunol. 173 (2004) 7017-7024
30. Okabe M., Ikawa M., Kominami K., Nakanishi T., and Nishimune Y. "Green mice" as a source of ubiquitous green cells. FEBS Lett. 407 (1997) 313-319
31. Parry C.M., Simas J.P., Smith V.P., Stewart C.A., Minson A.C., Efstathiou S., and Alcami A. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 191 (2000) 573-578
32. Proudfoot A.E., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., Borlat F., Wells T.N., and Kosco-Vilbois M.H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100 (2003) 1885-1890
33. Pyo R., Jensen K.K., Wiekowski M.T., Manfra D., Alcami A., Taubman M.B., and Lira S.A. Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3. Am. J. Pathol. 164 (2004) 2289-2297
34. Rot A. Endothelial cell binding of NAP-1/IL-8: Role in neutrophil emigration. Immunol. Today 13 (1992) 291-294
35. van Berkel V., Barrett J., Tiffany H.L., Fremont D.H., Murphy P.M., McFadden G., Speck S.H., and Virgin H.I. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J. Virol. 74 (2000) 6741-6747
36. Wiekowski M.T., Chen S.C., Zalamea P., Wilburn B.P., Kinsley D.J., Sharif W.W., Jensen K.K., Hedrick J.A., Manfra D., and Lira S.A. Disruption of neutrophil migration in a conditional transgenic model: Evidence for CXCR2 desensitization in vivo. J. Immunol. 167 (2001) 7102-7110
37. Yang T.Y., Chen S.C., Leach M.W., Manfra D., Homey B., Wiekowski M., Sullivan L., Jenh C.H., Narula S.K., Chensue S.W., and Lira S.A. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J. Exp. Med. 191 (2000) 445-454 (see comments)
38. Yoon J.W., Jun H.S., and Santamaria P. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 27 (1998) 109-122